Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge
Myeloid cells, especially dendritic cells and macrophages, play important roles in asthma pathophysiology. Monocytes (Mo) and macrophages express protease-activated receptor-2 (PAR-2), a proinflammatory serine protease receptor implicated in the pathophysiology of allergic airway inflammation. We ha...
Gespeichert in:
Veröffentlicht in: | Annals of allergy, asthma, & immunology asthma, & immunology, 2021-08, Vol.127 (2), p.249-256.e2 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 256.e2 |
---|---|
container_issue | 2 |
container_start_page | 249 |
container_title | Annals of allergy, asthma, & immunology |
container_volume | 127 |
creator | Palikhe, Nami Shrestha Gandhi, Vivek Dipak Wu, Yingqi Sinnatamby, Tristan Rowe, Brian H. Mayers, Irvin Cameron, Lisa Vliagoftis, Harissios |
description | Myeloid cells, especially dendritic cells and macrophages, play important roles in asthma pathophysiology. Monocytes (Mo) and macrophages express protease-activated receptor-2 (PAR-2), a proinflammatory serine protease receptor implicated in the pathophysiology of allergic airway inflammation. We have revealed that patients with severe asthma and those with a history of frequent asthma exacerbations exhibit increased PAR-2 expression on peripheral blood monocytes.
To determine PAR-2 expression on peripheral blood intermediate monocytes (IMMo) in subjects with increased airway inflammation, either as a result of an asthma exacerbation or after an inhalation allergen challenge.
A total of 16 adults who presented to the emergency department with asthma exacerbations were recruited after giving an informed consent. After 2 weeks, 10 patients returned for follow-up. A total of 11 patients with mild asthma treated only with as-needed bronchodilators were recruited and underwent inhalation allergen challenge after providing an informed consent. Immune cell profiling was performed by whole blood flow cytometry in both groups of patients.
PAR-2 expression in peripheral blood IMMo increased in patients with an asthma exacerbation compared with those with stable disease, but this expression decreased after treatment of the asthma exacerbation. Subjects with mild asthma had an increase in percentages of IMMo expressing PAR-2 after an allergen challenge. Patients who presented to the emergency department had lower dendritic cell and dendritic cell subset numbers in peripheral blood during exacerbation compared with after treatment.
Increased PAR-2 expression on Mo during periods of increased airway inflammation may initiate a positive feedback loop leading to systemic inflammatory changes. |
doi_str_mv | 10.1016/j.anai.2021.04.016 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2518741288</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1081120621002982</els_id><sourcerecordid>2518741288</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-9d90932cf69d90f2a7372eda8265e0cd33f45bba61a835819893a77ac554b0743</originalsourceid><addsrcrecordid>eNp9kc1O3DAUhSNUJCj0BVh52U1S_yVxpG4Qoj8SEizatXVj38x4lNip7UHlYfquOB3WrHx0_B1b956qumG0YZR1Xw4NeHANp5w1VDbFOqsuWStkLaXoPhRNFasZp91F9TGlA6WUqU5cVv-eMLp1jxFmMs4hWOJ8xrigdZCRLMEH81LEGkNGSFiDye65XFkS0eCaQ6w5wb9rxJRc8CVu4gYmYo_R-R2BlPcLFAQMxhFygRIBbwlM5aPC72H-7xKYZ4w79MTsN-l3eF2dTzAn_PR2XlW_v93_uvtRPzx-_3l3-1AbIUSuBzvQQXAzdZuaOPSi52hB8a5FaqwQk2zHEToGSrSKDWoQ0Pdg2laOtJfiqvp8ereM-eeIKevFJYPzDB7DMWneMtVLxpUqKD-hJoaUIk56jW6B-KIZ1VsX-qC3LvTWhaZSF6uEvp5CWIZ4dhh1Mg69KVsuW8zaBvde_BU1Epbz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2518741288</pqid></control><display><type>article</type><title>Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Palikhe, Nami Shrestha ; Gandhi, Vivek Dipak ; Wu, Yingqi ; Sinnatamby, Tristan ; Rowe, Brian H. ; Mayers, Irvin ; Cameron, Lisa ; Vliagoftis, Harissios</creator><creatorcontrib>Palikhe, Nami Shrestha ; Gandhi, Vivek Dipak ; Wu, Yingqi ; Sinnatamby, Tristan ; Rowe, Brian H. ; Mayers, Irvin ; Cameron, Lisa ; Vliagoftis, Harissios</creatorcontrib><description>Myeloid cells, especially dendritic cells and macrophages, play important roles in asthma pathophysiology. Monocytes (Mo) and macrophages express protease-activated receptor-2 (PAR-2), a proinflammatory serine protease receptor implicated in the pathophysiology of allergic airway inflammation. We have revealed that patients with severe asthma and those with a history of frequent asthma exacerbations exhibit increased PAR-2 expression on peripheral blood monocytes.
To determine PAR-2 expression on peripheral blood intermediate monocytes (IMMo) in subjects with increased airway inflammation, either as a result of an asthma exacerbation or after an inhalation allergen challenge.
A total of 16 adults who presented to the emergency department with asthma exacerbations were recruited after giving an informed consent. After 2 weeks, 10 patients returned for follow-up. A total of 11 patients with mild asthma treated only with as-needed bronchodilators were recruited and underwent inhalation allergen challenge after providing an informed consent. Immune cell profiling was performed by whole blood flow cytometry in both groups of patients.
PAR-2 expression in peripheral blood IMMo increased in patients with an asthma exacerbation compared with those with stable disease, but this expression decreased after treatment of the asthma exacerbation. Subjects with mild asthma had an increase in percentages of IMMo expressing PAR-2 after an allergen challenge. Patients who presented to the emergency department had lower dendritic cell and dendritic cell subset numbers in peripheral blood during exacerbation compared with after treatment.
Increased PAR-2 expression on Mo during periods of increased airway inflammation may initiate a positive feedback loop leading to systemic inflammatory changes.</description><identifier>ISSN: 1081-1206</identifier><identifier>EISSN: 1534-4436</identifier><identifier>DOI: 10.1016/j.anai.2021.04.016</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Annals of allergy, asthma, & immunology, 2021-08, Vol.127 (2), p.249-256.e2</ispartof><rights>2021 American College of Allergy, Asthma & Immunology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c333t-9d90932cf69d90f2a7372eda8265e0cd33f45bba61a835819893a77ac554b0743</citedby><cites>FETCH-LOGICAL-c333t-9d90932cf69d90f2a7372eda8265e0cd33f45bba61a835819893a77ac554b0743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.anai.2021.04.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids></links><search><creatorcontrib>Palikhe, Nami Shrestha</creatorcontrib><creatorcontrib>Gandhi, Vivek Dipak</creatorcontrib><creatorcontrib>Wu, Yingqi</creatorcontrib><creatorcontrib>Sinnatamby, Tristan</creatorcontrib><creatorcontrib>Rowe, Brian H.</creatorcontrib><creatorcontrib>Mayers, Irvin</creatorcontrib><creatorcontrib>Cameron, Lisa</creatorcontrib><creatorcontrib>Vliagoftis, Harissios</creatorcontrib><title>Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge</title><title>Annals of allergy, asthma, & immunology</title><description>Myeloid cells, especially dendritic cells and macrophages, play important roles in asthma pathophysiology. Monocytes (Mo) and macrophages express protease-activated receptor-2 (PAR-2), a proinflammatory serine protease receptor implicated in the pathophysiology of allergic airway inflammation. We have revealed that patients with severe asthma and those with a history of frequent asthma exacerbations exhibit increased PAR-2 expression on peripheral blood monocytes.
To determine PAR-2 expression on peripheral blood intermediate monocytes (IMMo) in subjects with increased airway inflammation, either as a result of an asthma exacerbation or after an inhalation allergen challenge.
A total of 16 adults who presented to the emergency department with asthma exacerbations were recruited after giving an informed consent. After 2 weeks, 10 patients returned for follow-up. A total of 11 patients with mild asthma treated only with as-needed bronchodilators were recruited and underwent inhalation allergen challenge after providing an informed consent. Immune cell profiling was performed by whole blood flow cytometry in both groups of patients.
PAR-2 expression in peripheral blood IMMo increased in patients with an asthma exacerbation compared with those with stable disease, but this expression decreased after treatment of the asthma exacerbation. Subjects with mild asthma had an increase in percentages of IMMo expressing PAR-2 after an allergen challenge. Patients who presented to the emergency department had lower dendritic cell and dendritic cell subset numbers in peripheral blood during exacerbation compared with after treatment.
Increased PAR-2 expression on Mo during periods of increased airway inflammation may initiate a positive feedback loop leading to systemic inflammatory changes.</description><issn>1081-1206</issn><issn>1534-4436</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc1O3DAUhSNUJCj0BVh52U1S_yVxpG4Qoj8SEizatXVj38x4lNip7UHlYfquOB3WrHx0_B1b956qumG0YZR1Xw4NeHANp5w1VDbFOqsuWStkLaXoPhRNFasZp91F9TGlA6WUqU5cVv-eMLp1jxFmMs4hWOJ8xrigdZCRLMEH81LEGkNGSFiDye65XFkS0eCaQ6w5wb9rxJRc8CVu4gYmYo_R-R2BlPcLFAQMxhFygRIBbwlM5aPC72H-7xKYZ4w79MTsN-l3eF2dTzAn_PR2XlW_v93_uvtRPzx-_3l3-1AbIUSuBzvQQXAzdZuaOPSi52hB8a5FaqwQk2zHEToGSrSKDWoQ0Pdg2laOtJfiqvp8ereM-eeIKevFJYPzDB7DMWneMtVLxpUqKD-hJoaUIk56jW6B-KIZ1VsX-qC3LvTWhaZSF6uEvp5CWIZ4dhh1Mg69KVsuW8zaBvde_BU1Epbz</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Palikhe, Nami Shrestha</creator><creator>Gandhi, Vivek Dipak</creator><creator>Wu, Yingqi</creator><creator>Sinnatamby, Tristan</creator><creator>Rowe, Brian H.</creator><creator>Mayers, Irvin</creator><creator>Cameron, Lisa</creator><creator>Vliagoftis, Harissios</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202108</creationdate><title>Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge</title><author>Palikhe, Nami Shrestha ; Gandhi, Vivek Dipak ; Wu, Yingqi ; Sinnatamby, Tristan ; Rowe, Brian H. ; Mayers, Irvin ; Cameron, Lisa ; Vliagoftis, Harissios</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-9d90932cf69d90f2a7372eda8265e0cd33f45bba61a835819893a77ac554b0743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Palikhe, Nami Shrestha</creatorcontrib><creatorcontrib>Gandhi, Vivek Dipak</creatorcontrib><creatorcontrib>Wu, Yingqi</creatorcontrib><creatorcontrib>Sinnatamby, Tristan</creatorcontrib><creatorcontrib>Rowe, Brian H.</creatorcontrib><creatorcontrib>Mayers, Irvin</creatorcontrib><creatorcontrib>Cameron, Lisa</creatorcontrib><creatorcontrib>Vliagoftis, Harissios</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of allergy, asthma, & immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Palikhe, Nami Shrestha</au><au>Gandhi, Vivek Dipak</au><au>Wu, Yingqi</au><au>Sinnatamby, Tristan</au><au>Rowe, Brian H.</au><au>Mayers, Irvin</au><au>Cameron, Lisa</au><au>Vliagoftis, Harissios</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge</atitle><jtitle>Annals of allergy, asthma, & immunology</jtitle><date>2021-08</date><risdate>2021</risdate><volume>127</volume><issue>2</issue><spage>249</spage><epage>256.e2</epage><pages>249-256.e2</pages><issn>1081-1206</issn><eissn>1534-4436</eissn><abstract>Myeloid cells, especially dendritic cells and macrophages, play important roles in asthma pathophysiology. Monocytes (Mo) and macrophages express protease-activated receptor-2 (PAR-2), a proinflammatory serine protease receptor implicated in the pathophysiology of allergic airway inflammation. We have revealed that patients with severe asthma and those with a history of frequent asthma exacerbations exhibit increased PAR-2 expression on peripheral blood monocytes.
To determine PAR-2 expression on peripheral blood intermediate monocytes (IMMo) in subjects with increased airway inflammation, either as a result of an asthma exacerbation or after an inhalation allergen challenge.
A total of 16 adults who presented to the emergency department with asthma exacerbations were recruited after giving an informed consent. After 2 weeks, 10 patients returned for follow-up. A total of 11 patients with mild asthma treated only with as-needed bronchodilators were recruited and underwent inhalation allergen challenge after providing an informed consent. Immune cell profiling was performed by whole blood flow cytometry in both groups of patients.
PAR-2 expression in peripheral blood IMMo increased in patients with an asthma exacerbation compared with those with stable disease, but this expression decreased after treatment of the asthma exacerbation. Subjects with mild asthma had an increase in percentages of IMMo expressing PAR-2 after an allergen challenge. Patients who presented to the emergency department had lower dendritic cell and dendritic cell subset numbers in peripheral blood during exacerbation compared with after treatment.
Increased PAR-2 expression on Mo during periods of increased airway inflammation may initiate a positive feedback loop leading to systemic inflammatory changes.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.anai.2021.04.016</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1081-1206 |
ispartof | Annals of allergy, asthma, & immunology, 2021-08, Vol.127 (2), p.249-256.e2 |
issn | 1081-1206 1534-4436 |
language | eng |
recordid | cdi_proquest_miscellaneous_2518741288 |
source | ScienceDirect Journals (5 years ago - present) |
title | Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A55%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peripheral%20blood%20intermediate%20monocyte%20protease-activated%20receptor-2%20expression%20increases%20during%20asthma%20exacerbations%20and%20after%20inhalation%20allergen%20challenge&rft.jtitle=Annals%20of%20allergy,%20asthma,%20&%20immunology&rft.au=Palikhe,%20Nami%20Shrestha&rft.date=2021-08&rft.volume=127&rft.issue=2&rft.spage=249&rft.epage=256.e2&rft.pages=249-256.e2&rft.issn=1081-1206&rft.eissn=1534-4436&rft_id=info:doi/10.1016/j.anai.2021.04.016&rft_dat=%3Cproquest_cross%3E2518741288%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2518741288&rft_id=info:pmid/&rft_els_id=S1081120621002982&rfr_iscdi=true |